Company Filing History:
1 out of 3,688 
1 out of 5,313 
Years Active: 2024
Title: Hao Wan: Innovator in Type 1 Diabetes Diagnosis
Introduction
Hao Wan is a notable inventor based in Stanford, California, recognized for his contributions to medical diagnostics. He has developed innovative methods that enhance the detection of antibodies related to type 1 diabetes, a significant advancement in the field of autoimmune diseases.
Latest Patents
Hao Wan holds a patent for a "Proteoliposome-based ZnT8 self-antigen for type 1 diabetes diagnosis." This patent describes methods for detecting ZNT8 antibodies in serum. The methods involve the use of proteoliposomes that contain a transmembrane domain and a cytosolic domain of ZnT8 proteins, which are exposed on the exterior of the proteoliposome. The process includes serum that contains antibodies targeting the ZnT8 proteins and labeled captured autoantibodies that bind to these antibodies.
Career Highlights
Throughout his career, Hao Wan has worked with prestigious institutions such as The Johns Hopkins University and Leland Stanford Junior University. His work has significantly contributed to the understanding and diagnosis of type 1 diabetes, showcasing his commitment to advancing medical science.
Collaborations
Hao Wan has collaborated with notable colleagues, including Dax Fu and Chengfeng Merriman. Their combined expertise has furthered the research and development of innovative diagnostic methods.
Conclusion
Hao Wan's contributions to the field of diabetes diagnosis through his innovative patent highlight his role as a leading inventor in medical technology. His work continues to impact the lives of those affected by type 1 diabetes.